Published in Clin Exp Nephrol on December 01, 2005
Autosomal dominant polycystic kidney disease: recent advances in pathogenesis and potential therapies. Clin Exp Nephrol (2012) 0.86
Human Evaluation of the Glu298Asp Polymorphism in NOS3 Gene and its Relationship with Onset age of ESRD in Iranian Patients Suffering from ADPKD. Int J Mol Cell Med (2012) 0.77
The L-arginine-nitric oxide pathway. N Engl J Med (1993) 14.38
TGF-beta signaling in fibroblasts modulates the oncogenic potential of adjacent epithelia. Science (2004) 10.23
Molecular cloning and expression of human hepatocyte growth factor. Nature (1989) 6.91
PKD2, a gene for polycystic kidney disease that encodes an integral membrane protein. Science (1996) 6.56
ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat Cell Biol (2001) 6.21
Polycystic kidney disease. N Engl J Med (2004) 5.73
The polycystic kidney disease proteins, polycystin-1, polycystin-2, polaris, and cystin, are co-localized in renal cilia. J Am Soc Nephrol (2002) 5.58
The polycystic kidney disease 1 (PKD1) gene encodes a novel protein with multiple cell recognition domains. Nat Genet (1995) 4.99
The gene mutated in autosomal recessive polycystic kidney disease encodes a large, receptor-like protein. Nat Genet (2002) 4.54
Polycystin-2 is an intracellular calcium release channel. Nat Cell Biol (2002) 4.37
Co-assembly of polycystin-1 and -2 produces unique cation-permeable currents. Nature (2001) 4.28
Mutations in a novel gene, NPHP3, cause adolescent nephronophthisis, tapeto-retinal degeneration and hepatic fibrosis. Nat Genet (2003) 4.14
Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med (2003) 3.78
Terminal differentiation of human breast cancer through PPAR gamma. Mol Cell (1998) 3.71
Polycystin-2 localizes to kidney cilia and the ciliary level is elevated in orpk mice with polycystic kidney disease. Curr Biol (2002) 3.55
Genetics and pathogenesis of polycystic kidney disease. J Am Soc Nephrol (2002) 3.52
Identification of telmisartan as a unique angiotensin II receptor antagonist with selective PPARgamma-modulating activity. Hypertension (2004) 3.51
Polycystic kidney disease: the complete structure of the PKD1 gene and its protein. The International Polycystic Kidney Disease Consortium. Cell (1995) 3.34
Comparison of phenotypes of polycystic kidney disease types 1 and 2. European PKD1-PKD2 Study Group. Lancet (1999) 3.32
Terminal differentiation of human liposarcoma cells induced by ligands for peroxisome proliferator-activated receptor gamma and the retinoid X receptor. Proc Natl Acad Sci U S A (1997) 3.22
Effective treatment of an orthologous model of autosomal dominant polycystic kidney disease. Nat Med (2004) 3.09
PKD1 induces p21(waf1) and regulation of the cell cycle via direct activation of the JAK-STAT signaling pathway in a process requiring PKD2. Cell (2002) 3.09
Induction of epithelial tubules by growth factor HGF depends on the STAT pathway. Nature (1998) 2.83
The renin-angiotensin-aldosterone system and autosomal dominant polycystic kidney disease. N Engl J Med (1990) 2.82
Identification and characterization of polycystin-2, the PKD2 gene product. J Biol Chem (1999) 2.74
Structure and chromosomal localization of the human constitutive endothelial nitric oxide synthase gene. J Biol Chem (1993) 2.69
Activation of PPARgamma leads to inhibition of anchorage-independent growth of human colorectal cancer cells. Gastroenterology (1998) 2.69
cAMP stimulates the in vitro proliferation of renal cyst epithelial cells by activating the extracellular signal-regulated kinase pathway. Kidney Int (2000) 2.65
Polycystin-2, the protein mutated in autosomal dominant polycystic kidney disease (ADPKD), is a Ca2+-permeable nonselective cation channel. Proc Natl Acad Sci U S A (2001) 2.62
The polycystic kidney disease 1 gene product modulates Wnt signaling. J Biol Chem (1999) 2.37
PPARgamma induces cell cycle withdrawal: inhibition of E2F/DP DNA-binding activity via down-regulation of PP2A. Genes Dev (1997) 2.29
Calcium restriction allows cAMP activation of the B-Raf/ERK pathway, switching cells to a cAMP-dependent growth-stimulated phenotype. J Biol Chem (2004) 2.26
Polycystin 1 is required for the structural integrity of blood vessels. Proc Natl Acad Sci U S A (2000) 2.23
Intracellular processing of endothelial nitric oxide synthase isoforms associated with differences in severity of cardiopulmonary diseases: cleavage of proteins with aspartate vs. glutamate at position 298. Proc Natl Acad Sci U S A (2000) 2.21
Cardiovascular, skeletal, and renal defects in mice with a targeted disruption of the Pkd1 gene. Proc Natl Acad Sci U S A (2001) 2.19
Comparison of Pkd1-targeted mutants reveals that loss of polycystin-1 causes cystogenesis and bone defects. Hum Mol Genet (2001) 2.09
Peroxisome proliferator-activated receptors (PPARs): novel therapeutic targets in renal disease. Kidney Int (2001) 2.08
Treatment of polycystic kidney disease with a novel tyrosine kinase inhibitor. Kidney Int (2000) 2.03
Loss of the polycystic kidney disease (PKD1) region of chromosome 16p13 in renal cyst cells supports a loss-of-function model for cyst pathogenesis. J Clin Invest (1997) 2.00
Polycystin-1, the gene product of PKD1, induces resistance to apoptosis and spontaneous tubulogenesis in MDCK cells. Mol Cell (2000) 1.94
Structural characterization of nitric oxide synthase isoforms reveals striking active-site conservation. Nat Struct Biol (1999) 1.93
Identification and localization of polycystin, the PKD1 gene product. J Clin Invest (1996) 1.84
Association of eNOS Glu298Asp polymorphism with end-stage renal disease. Hypertension (2002) 1.83
Expression of peroxisome proliferator-activated receptor gamma (PPARgamma) in human transitional bladder cancer and its role in inducing cell death. Neoplasia (1999) 1.78
Mutation analysis of the entire PKD1 gene: genetic and diagnostic implications. Am J Hum Genet (2000) 1.78
How to make tubes: signaling by the Met receptor tyrosine kinase. Trends Cell Biol (2003) 1.77
cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. J Am Soc Nephrol (2000) 1.76
Polycystin: in vitro synthesis, in vivo tissue expression, and subcellular localization identifies a large membrane-associated protein. Proc Natl Acad Sci U S A (1997) 1.75
A complete mutation screen of the ADPKD genes by DHPLC. Kidney Int (2002) 1.66
C-myc as an inducer of polycystic kidney disease in transgenic mice. Kidney Int (1991) 1.63
Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis. J Mol Endocrinol (2001) 1.63
Somatic mutation in individual liver cysts supports a two-hit model of cystogenesis in autosomal dominant polycystic kidney disease. Mol Cell (1998) 1.61
The position of the polycystic kidney disease 1 (PKD1) gene mutation correlates with the severity of renal disease. J Am Soc Nephrol (2002) 1.60
Identification, characterization, and localization of a novel kidney polycystin-1-polycystin-2 complex. J Biol Chem (2002) 1.56
Somatic PKD2 mutations in individual kidney and liver cysts support a "two-hit" model of cystogenesis in type 2 autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1999) 1.50
Polycystin-2 is a novel cation channel implicated in defective intracellular Ca(2+) homeostasis in polycystic kidney disease. Biochem Biophys Res Commun (2001) 1.48
Abnormal polarization of EGF receptors and autocrine stimulation of cyst epithelial growth in human ADPKD. Am J Physiol (1995) 1.48
Association of mutation position in polycystic kidney disease 1 (PKD1) gene and development of a vascular phenotype. Lancet (2003) 1.47
Pioglitazone improves the phenotype and molecular defects of a targeted Pkd1 mutant. Hum Mol Genet (2002) 1.43
Angiotensin II participates in mononuclear cell recruitment in experimental immune complex nephritis through nuclear factor-kappa B activation and monocyte chemoattractant protein-1 synthesis. J Immunol (1998) 1.41
Polycystin-1, the PKD1 gene product, is in a complex containing E-cadherin and the catenins. J Clin Invest (1999) 1.41
Left ventricular hypertrophy in autosomal dominant polycystic kidney disease. J Am Soc Nephrol (1997) 1.37
Targeting of the rasT24 oncogene to the proximal convoluted tubules in transgenic mice results in hyperplasia and polycystic kidneys. Am J Pathol (1993) 1.34
Vascular expression of polycystin-2. J Am Soc Nephrol (2001) 1.28
Polycystin: new aspects of structure, function, and regulation. J Am Soc Nephrol (2001) 1.27
Polycystins: from mechanosensation to gene regulation. Cell (2004) 1.25
Distribution and developmentally regulated expression of murine polycystin. Am J Physiol (1997) 1.23
1992 Homer Smith Award. Fluid secretion, cellular proliferation, and the pathogenesis of renal epithelial cysts. J Am Soc Nephrol (1993) 1.22
The secretion of fluid by renal cysts from patients with autosomal dominant polycystic kidney disease. N Engl J Med (1993) 1.22
Risk of advanced diabetic nephropathy in type 1 diabetes is associated with endothelial nitric oxide synthase gene polymorphism. Kidney Int (2000) 1.21
Polycystin-1, the product of the polycystic kidney disease 1 gene, co-localizes with desmosomes in MDCK cells. Hum Mol Genet (2000) 1.20
Modifier effect of ENOS in autosomal dominant polycystic kidney disease. Hum Mol Genet (2002) 1.20
Synthesis of renin by tubulocystic epithelium in autosomal-dominant polycystic kidney disease. Kidney Int (1992) 1.18
Gab1 is required for EGF receptor signaling and the transformation by activated ErbB2. Oncogene (2003) 1.15
Renal epithelial fluid secretion and cyst growth: the role of cyclic AMP. FASEB J (1989) 1.13
Mutation analysis of the entire replicated portion of PKD1 using genomic DNA samples. J Am Soc Nephrol (2001) 1.12
Homologues to the first gene for autosomal dominant polycystic kidney disease are pseudogenes. Genomics (2001) 1.11
Glomerulosclerosis and renal cysts in mice transgenic for the early region of SV40. Kidney Int (1987) 1.10
The unexpected landscape of in vivo somatic mutation in a human epithelial cell lineage. Proc Natl Acad Sci U S A (2002) 1.10
Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan. Nephron (1998) 1.09
Chloride and fluid secretion by cultured human polycystic kidney cells. Kidney Int (1996) 1.06
Distinct and common developmental expression patterns of the murine Pkd2 and Pkd1 genes. Mech Dev (2000) 1.06
Anion secretion drives fluid secretion by monolayers of cultured human polycystic cells. Am J Physiol (1995) 1.03
Germinal and somatic mutations in the PKD2 gene of renal cysts in autosomal dominant polycystic kidney disease. Hum Mol Genet (1999) 1.03
Endothelium-dependent relaxation of small resistance vessels is impaired in patients with autosomal dominant polycystic kidney disease. J Am Soc Nephrol (2000) 1.02
Biochemical characterization of bona fide polycystin-1 in vitro and in vivo. Am J Kidney Dis (2001) 1.01
Aberrant polycystin-1 expression results in modification of activator protein-1 activity, whereas Wnt signaling remains unaffected. J Biol Chem (2004) 1.00
Hepatocyte growth factor and the kidney. Curr Opin Nephrol Hypertens (2002) 1.00
Characterization and cell distribution of polycystin, the product of autosomal dominant polycystic kidney disease gene 1. Mol Med (1996) 0.99
Vasopressin V(2)-receptor-dependent regulation of AQP2 expression in Brattleboro rats. Am J Physiol Renal Physiol (2000) 0.99
Effects of angiotensin II and aldosterone on collagen gene expression and protein turnover in cardiac fibroblasts. Mol Cell Biochem (1996) 0.98
In vitro fluid secretion by epithelium from polycystic kidneys. J Clin Invest (1995) 0.98
Pathogenesis of hypertension in autosomal dominant polycystic kidney disease. Semin Nephrol (1991) 0.97
Polycystin-1 interacts with intermediate filaments. J Biol Chem (2001) 0.97
Mediation of renal cyst formation by hepatocyte growth factor. Lancet (1994) 0.96
Autosomal dominant polycystic kidney disease: clues to pathogenesis. Hum Mol Genet (1999) 0.95
Calcium channel blocker versus angiotensin II receptor blocker in autosomal dominant polycystic kidney disease. Nephron Clin Pract (2005) 0.94
Gab1 phosphorylation: a novel mechanism for negative regulation of HGF receptor signaling. Oncogene (2001) 0.92
Renal, cardiovascular and hormonal characteristics of young adults with autosomal dominant polycystic kidney disease. Kidney Int (1991) 0.92